ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 102 filers reported holding ASCENDIS PHARMA A/S in Q2 2018. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,323,000 | -75.1% | 25,258 | -75.6% | 0.00% | -80.0% |
| Q1 2021 | $13,323,000 | -32.4% | 103,376 | -12.5% | 0.01% | -33.3% |
| Q4 2020 | $19,700,000 | +28.1% | 118,121 | +18.5% | 0.02% | +7.1% |
| Q3 2020 | $15,383,000 | +17.3% | 99,680 | +12.4% | 0.01% | +7.7% |
| Q2 2020 | $13,115,000 | +114.9% | 88,678 | +63.6% | 0.01% | +85.7% |
| Q1 2020 | $6,103,000 | -18.5% | 54,200 | +0.7% | 0.01% | 0.0% |
| Q4 2019 | $7,485,000 | +80.3% | 53,800 | +24.8% | 0.01% | +75.0% |
| Q3 2019 | $4,151,000 | +46.5% | 43,100 | +75.2% | 0.00% | +33.3% |
| Q2 2019 | $2,833,000 | -11.4% | 24,600 | -9.5% | 0.00% | -25.0% |
| Q1 2019 | $3,198,000 | +18.2% | 27,175 | -37.1% | 0.00% | 0.0% |
| Q4 2018 | $2,706,000 | -15.7% | 43,192 | -4.6% | 0.00% | 0.0% |
| Q3 2018 | $3,209,000 | +70.6% | 45,292 | +60.1% | 0.00% | +33.3% |
| Q2 2018 | $1,881,000 | -35.0% | 28,281 | -36.1% | 0.00% | -25.0% |
| Q1 2018 | $2,894,000 | +256.8% | 44,255 | +118.7% | 0.00% | +300.0% |
| Q4 2017 | $811,000 | +13.7% | 20,235 | +2.9% | 0.00% | 0.0% |
| Q3 2017 | $713,000 | +65.8% | 19,658 | +26.8% | 0.00% | 0.0% |
| Q2 2017 | $430,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |